Vanda Pharmaceuticals Announces Participation at September 2025 Investor Conferences
Vanda Pharmaceuticals (Nasdaq: VNDA) has announced its participation in three major healthcare investor conferences in September 2025. The company will present at the Cantor Global Healthcare Conference in New York on September 3 at 3:55 PM ET, the Wells Fargo Healthcare Conference in Boston on September 4 at 4:30 PM ET, and the H.C. Wainwright Annual Global Investment Conference in New York on September 9 at 8:30 AM ET.
All presentations will be accessible through live webcasts on Vanda's corporate website, with archived versions available for approximately 30 days following the events.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha annunciato la sua partecipazione a tre importanti conferenze per investitori del settore sanitario a settembre 2025. L'azienda terrà presentazioni al Cantor Global Healthcare Conference a New York il 3 settembre alle 15:55 ET, al Wells Fargo Healthcare Conference a Boston il 4 settembre alle 16:30 ET e all'H.C. Wainwright Annual Global Investment Conference a New York il 9 settembre alle 08:30 ET.
Tutte le presentazioni saranno trasmesse in diretta via webcast sul sito aziendale di Vanda, con le registrazioni disponibili in archivio per circa 30 giorni dopo gli eventi.
Vanda Pharmaceuticals (Nasdaq: VNDA) ha anunciado su participación en tres importantes conferencias para inversores del sector sanitario en septiembre de 2025. La compañía realizará presentaciones en el Cantor Global Healthcare Conference en Nueva York el 3 de septiembre a las 3:55 PM ET, en el Wells Fargo Healthcare Conference en Boston el 4 de septiembre a las 4:30 PM ET y en el H.C. Wainwright Annual Global Investment Conference en Nueva York el 9 de septiembre a las 8:30 AM ET.
Todas las presentaciones se podrán seguir por webcast en directo desde la web corporativa de Vanda, y las grabaciones quedarán disponibles en archivo durante aproximadamente 30 días tras los eventos.
Vanda Pharmaceuticals (Nasdaq: VNDA)는 2025년 9월에 열리는 주요 헬스케어 투자자 회의 세 곳에 참가한다고 발표했습니다. 회사는 9월 3일 오전 3시 55분(ET)에 뉴욕에서 열리는 Cantor Global Healthcare Conference에서, 9월 4일 오후 4시 30분(ET)에 보스턴에서 열리는 Wells Fargo Healthcare Conference에서, 그리고 9월 9일 오전 8시 30분(ET)에 뉴욕에서 열리는 H.C. Wainwright Annual Global Investment Conference에서 발표할 예정입니다.
모든 발표는 Vanda의 기업 웹사이트를 통해 실시간 웹캐스트로 시청할 수 있으며, 행사 종료 후 약 30일간 아카이브로 제공됩니다.
Vanda Pharmaceuticals (Nasdaq: VNDA) a annoncé sa participation à trois grandes conférences dédiées aux investisseurs en santé en septembre 2025. La société présentera au Cantor Global Healthcare Conference à New York le 3 septembre à 15h55 ET, au Wells Fargo Healthcare Conference à Boston le 4 septembre à 16h30 ET, et au H.C. Wainwright Annual Global Investment Conference à New York le 9 septembre à 08h30 ET.
Toutes les présentations seront diffusées en direct via webcast sur le site corporate de Vanda, les enregistrements restant accessibles en archive pendant environ 30 jours après les événements.
Vanda Pharmaceuticals (Nasdaq: VNDA) hat seine Teilnahme an drei bedeutenden Healthcare-Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird am Cantor Global Healthcare Conference in New York am 3. September um 15:55 Uhr ET, am Wells Fargo Healthcare Conference in Boston am 4. September um 16:30 Uhr ET sowie am H.C. Wainwright Annual Global Investment Conference in New York am 9. September um 08:30 Uhr ET präsentieren.
Alle Präsentationen werden live per Webcast auf der Unternehmenswebsite von Vanda übertragen; Aufzeichnungen stehen etwa 30 Tage nach den Veranstaltungen im Archiv zur Verfügung.
- None.
- None.
The Cantor Global Healthcare Conference 2025 in
The 2025 Wells Fargo Healthcare Conference in
The H.C. Wainwright Annual Global Investment Conference in
The corporate presentations given at the Cantor, Wells Fargo and H.C. Wainwright conferences may be accessed live on Vanda's corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-september-2025-investor-conferences-302541540.html
SOURCE Vanda Pharmaceuticals Inc.
FAQ
When is Vanda Pharmaceuticals (VNDA) presenting at the Cantor Global Healthcare Conference 2025?
How can investors access Vanda Pharmaceuticals' (VNDA) September 2025 conference presentations?
Which investor conferences will Vanda Pharmaceuticals (VNDA) attend in September 2025?
What time is Vanda Pharmaceuticals' (VNDA) presentation at the Wells Fargo Healthcare Conference 2025?
